Abbott Laboratories' stock opened lower on Friday, dropping from $129.89 to $125.00 before trading at $126.04. Despite this ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Bank of America raised Abbott Laboratories’ price target from $133 to $150, maintaining a buy rating on the stock. Other ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

Two former employees say the Scarborough plant failed to accommodate their disabilities and created a hostile work ...

ByReuters • Jan 25, 2017 Abbott Labs Q4 EPS $0.65 in line with estimates as revenues fall short Investing.com - (NYSE:Abbott Labs) fourth quarter earnings in line with estimates as revenues fell ...

After hours: March 14 at 7:59:08 PM EDT Loading Chart for ABT ...